PhRMA Foundation names president

WASHINGTON — The Pharmaceutical Research and Manufacturers of America Foundation on Tuesday named Eileen Cannon president.

 

“On behalf of our member companies and staff, I’d like to congratulate Eileen on her well-deserved promotion to president of the PhRMA Foundation,” stated John Castellani, president and CEO, PhRMA. “Over the past 15 years, Eileen’s leadership has been instrumental in helping to connect promising young researchers to resources that not only help launch their careers, but also help to advance critical new science that contributes to the drug discovery process for patients.”

 

This year, the foundation is celebrating its 50th anniversary and its tradition of fostering the development of highly-trained, top-quality scientists to help address the growing needs of stakeholders in the biopharmaceutical sector, including scientific and academic institutions, government and the biopharmaceutical industry. Having funded the research of more than 2,200 young scientists, the Foundation continues its contribution to the future of care for patients.

 

Cannon has played a central role in the foundation’s expansion during her tenure. Over the last several years, she has helped implement new initiatives in regulatory science, comparative effectiveness research, translational medicine and safe and effective prescribing.

 

Cannon’s leadership has also contributed to the development of new partnerships with national scientific organizations and government agencies, such as the National Institute of Health and the Foundation of the National Institute of Health. This collaboration has led to the creation of education initiatives that are critical to biopharmaceutical research and development, practicing physicians and patients.